Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Dynavax Technologies Corp’s current trading price is -25.15% away from its 52-week high, while its distance from the 52-week low is 18.76%. The stock’s price range during this period has varied between $9.22 and $14.63. The company, active in the Healthcare sector, saw a trading volume of around 4.46 million for the day, considerably higher average daily volume of 1.58 million observed over the last three months.
Dynavax Technologies Corp (DVAX) has a current stock price of $10.95. During the previous trading session, the stock witnessed a notable rise, reaching a high of $32.0 after opening at $10.95. The stock’s low for the day was $11.0, and it eventually closed at $10.42.
The stock market performance of Dynavax Technologies Corp has been fairly unsteady. Over the last year, the company’s stock hit its highest at $14.63 on 03/07/25, while the lowest price during the same time frame was $9.22, recorded on 05/14/25.
How Financial Performance Impacts Market Capitalization
Dynavax Technologies Corp (DVAX) has experienced a quarterly rise of 10.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.28B and boasts a workforce of 405 employees.
Decoding Analysts’ Ratings for Dynavax Technologies Corp
As of right now, 3 analysts are rating Dynavax Technologies Corp as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.65, with a change in price of -2.73. Similarly, Dynavax Technologies Corp recorded 2,024,938 in trading volume during the last 100 days, posting a change of -19.96%.
How DVAX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for DVAX stands at 0.59. Similarly, the long-term debt-to-equity ratio is also 0.50.
DVAX Stock Stochastic Average
As of today, the raw stochastic average of Dynavax Technologies Corp over the past 50 days is 53.94%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 49.66%. Additionally, the Stochastic %K and %D values for the company were 34.69% and 34.64%, respectively, over the past 20 days.
DVAX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -4.37% this year. Over the last six months, there has been a stronger performance of -17.85%. The price of DVAX leaped by -3.52% during the last 30 days period. For the last 5-days stocks have improved 3.11%.
